Literature DB >> 3139438

An investigation of local actions of ionophoretically applied DOPA in the spinal cord.

H Bras1, P Cavallari, E Jankowska.   

Abstract

Methyl-L-DOPA (L-beta-3,4-dihydroxy-phenylalanine methyl ester, hydrochloride) was applied ionophoretically to investigate its effects on neurones at various locations in the cat spinal cord. Its actions were tested on monosynaptic field potentials evoked from group I and group II muscle afferents in midlumbar segments. Methyl-L-DOPA has been found to depress field potentials evoked from group II afferents in the ventral horn and in the intermediate zone but not in the dorsal horn, nor field potentials evoked from group I afferents. Its effects were the same as those of systemically applied L-DOPA (L-beta-3,4-dihydroxyphenylalanine), although weaker.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139438     DOI: 10.1007/bf00247506

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  8 in total

1.  5-HYDROXYTRYPTAMINE OF THE SPINAL CORD NORMALLY AND AFTER TRANSECTION.

Authors:  A CARLSSON; T MAGNUSSON; E ROSENGREN
Journal:  Experientia       Date:  1963-07-15

2.  Field potentials generated by group II muscle afferents in the middle lumbar segments of the cat spinal cord.

Authors:  S A Edgley; E Jankowska
Journal:  J Physiol       Date:  1987-04       Impact factor: 5.182

3.  Supraspinal and segmental control of static and dynamic gamma-motoneurones in the cat.

Authors:  S Grillner
Journal:  Acta Physiol Scand Suppl       Date:  1969

4.  Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.

Authors:  L L Butcher; J Engel; K Fuxe
Journal:  Brain Res       Date:  1972-06-22       Impact factor: 3.252

5.  The effect of DOPA on the spinal cord. 5. Reciprocal organization of pathways transmitting excitatory action to alpha motoneurones of flexors and extensors.

Authors:  E Jankowska; M G Jukes; S Lund; A Lundberg
Journal:  Acta Physiol Scand       Date:  1967 Jul-Aug

6.  [Stepping movements in the spinal cat after DOPA injection].

Authors:  N N Budakova
Journal:  Fiziol Zh SSSR Im I M Sechenova       Date:  1973-08

7.  The effect of DOPA on the spinal cord. 1. Influence on transmission from primary afferents.

Authors:  N E Andén; M G Jukes; A Lundberg; L Vyklický
Journal:  Acta Physiol Scand       Date:  1966 Jul-Aug

8.  The effect of DOPA on the spinal cord. 2. A pharmacological analysis.

Authors:  N E Andén; M G Jukes; A Lundberg
Journal:  Acta Physiol Scand       Date:  1966 Jul-Aug
  8 in total
  6 in total

1.  Initiating or blocking locomotion in spinal cats by applying noradrenergic drugs to restricted lumbar spinal segments.

Authors:  J Marcoux; S Rossignol
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

2.  Limitedly selective action of a delta-agonistic leu-enkephalin on the transmission in spinal motor reflex pathways in cats.

Authors:  P F Schmidt; E D Schomburg; H Steffens
Journal:  J Physiol       Date:  1991-10       Impact factor: 5.182

3.  Influence of the pontine and medullary reticular formation on synchrony of gamma motoneurone discharge in the cat.

Authors:  J R Baker; M C Catley; N J Davey; P H Ellaway
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

4.  Gating of transmission to motoneurones by stimuli applied in the locus coeruleus and raphe nuclei of the cat.

Authors:  E Jankowska; J S Riddell; B Skoog; B R Noga
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

5.  Comparison of effects of monoamines on transmission in spinal pathways from group I and II muscle afferents in the cat.

Authors:  H Bras; P Cavallari; E Jankowska; D McCrea
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

6.  Influence of opioids and naloxone on rhythmic motor activity in spinal cats.

Authors:  E D Schomburg; H Steffens
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.